KALV earnings: a positive outcome, +9.2%

On March 16, 2018, KalVista Pharmaceuticals, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.2% in the window around the event. It had already run -8.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.